People: Biologist Fink Follows David Baltimore As Director Of MIT's Whitehead Institute

Gerald R. Fink, American Cancer Society Professor of Genetics at the Massachusetts Institute of Technology's Whitehead Institute for Biomedical Research, has been named the new director of the institute. Fink will assume the post July 1, succeeding David Baltimore, who has accepted the presidency of Rockefeller University. Fink was nominated by an eight-member search committee composed of MIT and Whitehead Institute faculty members, with the final selection being made by Whitehead's board of d

Written byColby Stong
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Gerald R. Fink, American Cancer Society Professor of Genetics at the Massachusetts Institute of Technology's Whitehead Institute for Biomedical Research, has been named the new director of the institute. Fink will assume the post July 1, succeeding David Baltimore, who has accepted the presidency of Rockefeller University.

Fink was nominated by an eight-member search committee composed of MIT and Whitehead Institute faculty members, with the final selection being made by Whitehead's board of directors. The Whitehead Institute is a nonprofit, independent basic research and teaching institution currently focusing research efforts on developmental biology.

Fink, 49, and also a professor in MIT's Department of Biology, sees recruiting young faculty and developing "first-rate scientists" among his priorities as new director. "I have an opportunity to develop some very good scientists," says Fink. "I feel like someone who has been given a gem," he says, referring to Whitehead's faculty and scientists. "The idea ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies